Tezakaftor: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
kTidak ada ringkasan suntingan
Baris 1:
{{Infobox drug
{{Drugbox|drug_name=|type=<!-- empty -->|IUPAC_name=1-(2,2-Difluoro-1,3-benzodioxol-5-yl)-''N''-[1-[(2''R'')-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1''H''-indol-5-yl]-cyclopropanecarboxamide|image=Tezacaftor.svg|alt=200px|caption=<!-- Clinical data -->|tradename=Symdeko (with [[ivacaftor]])|Drugs.com=|MedlinePlus=|pregnancy_AU=<!-- A/B1/B2/B3/C/D/X -->|pregnancy_US=<!-- A/B/C/D/X/N -->|pregnancy_category=|routes_of_administration=|legal_AU=<!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->|legal_CA=<!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->|legal_UK=<!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM / Class A, B, C -->|legal_US=<!-- OTC/Rx-only/Schedule I, II, III, IV, V -->|legal_status=<!-- Free text -->
| drug_name =
<!-- Pharmacokinetic data -->|bioavailability=|protein_bound=|metabolism=|elimination_half-life=|excretion=<!-- Identifiers -->|CAS_number=1152311-62-0|UNII=8RW88Y506K|ATCvet=|ATC_prefix=<!-- 'none' if uncategorised -->|ATC_suffix=|PubChem=46199646|DrugBank=DB11712|KEGG=D11041
| INN =
<!-- Chemical and physical data -->|C=26|H=27|F=3|N=2|O=6}}
| type =<!-- empty -->
| IUPAC_name = 1-(2,2-Difluoro-1,3-benzodioxol-5-yl)-''N''-[1-[(2''R'')-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1''H''-indol-5-yl]-cyclopropanecarboxamide
| image = Tezacaftor.svg
| alt = 200px
| caption =
<!-- Clinical data -->
| pronounce =
| tradename = Symdeko (dengan [[ivakaftor]])
| Drugs.com =
| MedlinePlus =
| pregnancy_AU = <!-- A/B1/B2/B3/C/D/X -->
| pregnancy_AU_comment =
| pregnancy_US = <!-- A/B/C/D/X/N -->
| pregnancy_category=
| routes_of_administration =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_AU_comment =
| legal_BR = <!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F-->
| legal_BR_comment =
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_DE = <!-- Anlage I, II, III -->
| legal_NZ = <!-- Class A, B, C -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM / Class A, B, C -->
| legal_US = <!-- OTC/Rx-only/Schedule I, II, III, IV, V -->
| legal_UN = <!-- N I, II, III, IV / P I, II, III, IV-->
| legal_status = <!-- Free text -->
<!-- Pharmacokinetic data -->
| bioavailability =
| protein_bound =
| metabolism =
| metabolites =
| onset =
| elimination_half-life =
| duration_of_action =
| excretion =
<!-- Identifiers -->
| CAS_number = 1152311-62-0
| UNII = 8RW88Y506K
| class =
| ATCvet =
| ATC_prefix = <!-- 'none' if uncategorised -->
| ATC_suffix =
| PubChem = 46199646
| DrugBank = DB11712
| KEGG = D11041
<!-- Chemical and physical data -->|C=26|H=27|F=3|N=2|O=6}}
| C=26|H=27|F=3|N=2|O=6
}}
'''Tezakaftor''', juga dikenal sebagai VX-661 adalah obat yang disetujui oleh FDA untuk mengobati beberapa kasus [[Fibrosis sistik|fibrosis kistik]].